Inside Innovation

Magnolia Medical, a Seattle-based biotech company, raised $46 million to further propel product innovation. This financing follows a record-setting new account acquisition and top-line sales

Cuervo Vaccine, a Seattle-based company, recently secured $60 million in a Series A financing round. The company, which works to develop safe and highly effective

Cell therapy company Juno Therapeutics was sold to Celgene in 2018, but its impact still reverberates throughout Seattle’s life science industry today. The company’s successes

Bristol Myers Squibb announced its newest round of funding as part of its 2020 pledge to donate $150 million over the next five years to

Vancouver, Washington is experiencing a biotech boom, fueled by companies like Absci, CytoDyn and Capsigen who are leading the way in developing new technologies to

As the search for what causes long-COVID continues, researchers at Seattle’s Institute for Systems Biology may have found some answers as to what factors cause

Life Science Washington’s latest Economic Impact Reports reveals a 23.5% rise in employment in the field from 2015-2019, reflecting tremendous growth in the region as

Spokane, Washington-based startup Parrots Inc. is gaining recognition for its innovative AI-powered product that helps individuals using wheelchairs communicate and navigate their surroundings more efficiently.

The University of Washington School of Pharmacy’s Drug Interaction Database has been awarded the Gary Neil Prize for Innovation in Drug Development from the American

A group of cancer research experts are teaming up to launch Affini-T Therapeutics, which aims to develop cancer treatments using T cell receptor (TCR) cancer

Amidst several mergers, acquisitions and funding rounds in the last year, Seattle Inno has named 22 startups to watch in 2022, including Mozart Therapeutics. The

Marc Cummings, former VP of public policy and external affairs at Life Science Washington, has been named President and CEO of the trade association. “It’s